Premium
Electrically Controlled Neurochemical Release from Dual‐Layer Conducting Polymer Films for Precise Modulation of Neural Network Activity in Rat Barrel Cortex
Author(s) -
Du Zhanhong Jeff,
Bi GuoQiang,
Cui Xinyan Tracy
Publication year - 2018
Publication title -
advanced functional materials
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.069
H-Index - 322
eISSN - 1616-3028
pISSN - 1616-301X
DOI - 10.1002/adfm.201703988
Subject(s) - dnqx , materials science , coating , microelectrode , layer (electronics) , biomedical engineering , electrode , nanotechnology , silanization , multielectrode array , composite material , chemistry , medicine , biochemistry , glutamate receptor , receptor , ampa receptor
Implantable microelectrode arrays (MEAs) are important tools for investigating functional neural circuits and treating neurological diseases. Precise modulation of neural activity may be achieved by controlled delivery of neurochemicals directly from coatings on MEA electrode sites. In this study, a novel dual‐layer conductive polymer/acid functionalized carbon nanotube (fCNT) microelectrode coating is developed to better facilitate the loading and controlled delivery of the neurochemical 6,7‐dinitroquinoxaline‐2,3‐dione (DNQX). The base layer coating is consisted of poly(3,4‐ethylenedioxythiophene/fCNT and the top layer is consisted of polypyrrole/fCNT/DNQX. The dual‐layer coating is capable of both loading and electrically releasing DNQX and the release dynamic is characterized with fluorescence microscopy and mathematical modeling. In vivo DNQX release is demonstrated in rat somatosensory cortex. Sensory‐evoked neural activity is immediately (<1s) and locally (<446 µm) suppressed by electrically triggered DNQX release. Furthermore, a single DNQX‐loaded, dual‐layer coating is capable of inducing effective neural inhibition for at least 26 times without observable degradation in efficacy. Incorporation of the novel drug releasing coating onto individual MEA electrodes offers many advantages over alternative methods by increasing spatial‐temporal precision and improving drug selection flexibility without increasing the device's size.